- Neuro-All - University of Manitoba Mailing Lists

FW: Dementia Manitoba website - request for updates
by Manitoba Neuroscience Network 14 Feb '19

14 Feb '19

cid:image001.jpg@01D158FE.B69B8D00 /sent on behalf of Ben Albensi Hi All Our Dementia Manitoba website is currently being updated. If you have any new studies or reviews on Alzheimer's and/or dementia and would like to have your lab recognized then please send me your information for posting. Or just check out what's new and upcoming. Thanks, http://dementiamanitoba.wixsite.com/mysite/research-blog Dr George Perry visits the TMS and EVestG labs in Winnipeg. Benedict C. Albensi, PhD Dementia Research Chair University of Manitoba & St Boniface Hospital Research 204-235-3942

1 0

MNN Visiting Speaker - Dr. Alyson Fournier | Wed Mar 20 @ 12 noon
by Manitoba Neuroscience Network 07 Feb '19

07 Feb '19

Please mark your calendar cid:image001.jpg@01D158FE.B69B8D00 M N N S E M I N A R & V I S I T I N G S P E A K E R S E R I E S D A T E Wednesday, Mar 20, 2019 12 noon L O C A T I O N: Theatre B Bannatyne Campus fourniersmall.jpgS P E A K E R Dr. Alyson Fournier <https://www.mcgill.ca/neuro/research/researchers/fournier> Professor Faculty of Medicine McGill University T O P I C Small molecule stabilization of protein Interactions to promote axon regeneration Abstract Damaged central nervous system (CNS) neurons have a poor ability to spontaneously regenerate, causing persistent functional deficits after injury. Therapies that stimulate axon growth are needed to repair CNS damage. 14-3-3 adaptors are hub proteins that are attractive targets to manipulate cell signaling. We have identified a positive role for 14-3-3s in axon growth and have shown that fusicoccin-A (FC-A), a small-molecule stabilizer of 14-3-3 protein-protein interactions, stimulates axon growth in vitro and regeneration in vivo. Further screening of FC-A derivatives has revealed potent axon growth-promoting compounds. Through mass spectrometry, we find that FC-A and a potent derivative, stabilize interactions between 14-3-3 proteins and multiple components of the Rap1 pathway to facilitate axon growth. Thus, FC-A and its derivatives exhibit remarkable polypharmacology facilitating axon regeneration. These findings show that 14-3-3 adaptor protein complexes are druggable targets and identify a new class of small molecules that may be further optimized for the repair of CNS damage Objectives * Define 14-3-3- adaptor proteins and small molecules targeting these proteins * Describe the influence of small molecules targeting 14-3-3 proteins on axon regeneration in a pre-clinical optic nerve injury model * Discuss the mechanism used by these small molecules to promote axon regeneration Short Bio Dr. Alyson Fournier (PhD) is a Professor in the Faculty of Medicine at McGill University in Montreal, Canada. She completed her Ph.D. in Neuroscience at McGill University (1998) and conducted her postdoctoral training at Yale University with Dr. Strittmatter working on neurodevelopment and regeneration. Since 2003 Dr. Fournier has led a research lab at the Montreal Neurological Institute studying molecular mechanisms regulating axon degeneration and regeneration. Dr. Fourniers group studies neuronal signalling in response to acute nerve cell injury and inflammation for the conception and validation of new therapeutic targets to promote neuroprotection and repair. /sent on behalf of Tabrez Siddiqui Chair Seminar Series Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

1 0

Video link to Dr Perry's talk
by Manitoba Neuroscience Network 07 Feb '19

07 Feb '19

/sent on behalf of Ben Albensi cid:image001.jpg@01D158FE.B69B8D00 All We were able to record Dr. Perry's talk held on Monday Feb 4th, 2019. Here is the link for those interested. http://media1.cc.umanitoba.ca/legacy/bann/eos/eos_2019_02_04.mp4 Regards, Ben D A T E: Monday, Feb 4, 2019 12:00 Noon L O C A T I O N: Theatre A Bannatyne Campus **followed by a trainee lunch in 207 A&B Chown Bldg. S P E A K E R: Image result for dr george perryGeorge Perry PhD Professor of Biology and Chemistry Chief Scientist, Brain Health Consortium Semmes Foundation Distinguished University Chair in Neurobiology The University of Texas at San Antonio T O P I C: Mitochondria At The Center Of Alzheimer's Disease Dr. Perry's studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer's disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimer's disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals.

1 0

SCRC Journal Club Feb.8 - Nagakannan Pandian
by Manitoba Neuroscience Network 07 Feb '19

07 Feb '19

cid:image001.jpg@01D158FE.B69B8D00 /sent on behalf of Mona Nazzal and Katinka Stecina Subject: SCRC Journal Club Feb.8 - Nagakannan Pandian Hello all, For this Friday's Journal club we will have a presentation by Nagakannan Pandian, a PhD student from the Eftekharpour lab. He will be presenting a talk entitled "Ferroptosis in Neuronal Cell Death" See you all on Friday! 11am to noon room 405 of Brodie Centre ----------------------------------------------------------------------- Mona Nazzal PhD Student Spinal Cord Research Centre Department of Physiology and Pathophysiology University of Manitoba 425 BMSB-745 Bannatyne Ave Winnipeg, MB R3E 0J9

1 0

Edge of Science & Medicine Visiting Speaker Series - Dr. George Perry Feb 4/2019
by Manitoba Neuroscience Network 03 Feb '19

03 Feb '19

cid:image001.jpg@01D158FE.B69B8D00 /sent on behalf of Dr. Ben Albensi Everyone is invited! D A T E: Monday, Feb 4, 2019 12:00 Noon L O C A T I O N: Theatre A Bannatyne Campus **followed by a trainee lunch in 207 A&B Chown Bldg. S P E A K E R: Image result for dr george perryGeorge Perry PhD Professor of Biology and Chemistry Chief Scientist, Brain Health Consortium Semmes Foundation Distinguished University Chair in Neurobiology The University of Texas at San Antonio T O P I C: Mitochondria At The Center Of Alzheimers Disease Dr. Perrys studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimers disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimers disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

2 1

**REVISED***Special Lecture - John Wallace Feb 1 @ 9am
by Kelly Jorundson 31 Jan '19

31 Jan '19

[cid:image001.jpg@01D158FE.B69B8D00] /sent on behalf of Mary Fry All faculty, staff and students are welcome to attend. Faculty and students interested in meeting the speakers can contact Mark Fry (Mark.Fry(a)umanitoba.ca<mailto:Mark.Fry@umanitoba.ca>) or Kevin Scott (Kevin.Scott(a)umanitoba.ca<mailto:Kevin.Scott@umanitoba.ca>) for more information. Special Cross-Disciplinary Seminar hosted by Department of Biological Sciences Date: Friday, Feb 1st, 2019 Time: 9:00am Location: Room 207 Buller BLDG Speaker: John L. Wallace Professor of Physiology & Pharmacology University of Calgary Topic: A gas from the Past: Adventures in Drug Discovery". Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca> Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

MNN Seminar - Feb 22 - Stephanie Booth ***CANCELLED**
by Kelly Jorundson 31 Jan '19

31 Jan '19

[cid:image001.jpg@01D158FE.B69B8D00] Please note that the MNN seminar scheduled for February 22nd, 2019 has been cancelled. Apologies for any inconvenience. /sent on behalf of Tabrez Siddiqui Chair, Seminar Series Manitoba Neuroscience Network Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca> Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

Special Lecture - John Wallace Feb 1 @ 9am
by Kelly Jorundson 31 Jan '19

31 Jan '19

[cid:image001.jpg@01D158FE.B69B8D00] /sent on behalf of Mary Fry All faculty, staff and students are welcome to attend. Faculty and students interested in meeting the speakers can contact Mark Fry (Mark.Fry(a)umanitoba.ca<mailto:Mark.Fry@umanitoba.ca>) or Kevin Scott (Kevin.Scott(a)umanitoba.ca<mailto:Kevin.Scott@umanitoba.ca>) for more information. Special Cross-Disciplinary Seminar hosted by Department of Biological Sciences Date: Friday, Feb 1st, 2019 Time: 9:00am Location: Room 207 JBRC Speaker: John L. Wallace Professor of Physiology & Pharmacology University of Calgary Topic: A gas from the Past: Adventures in Drug Discovery". Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca> Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

Reminder: MNN Seminar Series - Dr. Saeid Ghavami Fri Jan 25th @9am
by Manitoba Neuroscience Network 21 Jan '19

21 Jan '19

cid:image001.jpg@01D158FE.B69B8D00 M N N S E M I N A R & V I S I T I N G S P E A K E R S E R I E S D A T E Friday, January 25th, 2019 9am L O C A T I O N: Px236/238 PsycHealth Bldg. Bannatyne Campus S P E A K E R Dr. Saeid Ghavami Assistant Professor Human Anatomy & Cell Science Rady Faculty of Health Sciences T O P I C Glioblastoma and Cholesterol Metabolism Pathway Abstract: Temozolomide (TMZ) is chemotherapeutic agent for treatment of Grade IV Astrocytoma, otherwise known as Glioblastoma multiforme (GBM). TMZ treatment causes DNA damage and results in tumor cell apoptosis. TMZ also induces autophagy and causes tumor cell resistance and thus fails to improve the survival rate among patients. Statins are competitive inhibitors of the rate determining enzyme of the mevalonate (MEV) cascade and best known for their cholesterol (CH) lowering effect. Recently, it was reported that long-term consumption of statins, prior to and in parallel with other cancer therapeutic approaches, increased the survival rate of patients with various forms of cancers. In this talk, I present our latest investigation about the mechanisms of the potentiation of TMZ-induced apoptosis by MEV cascade inhibitor (cholesterol biosynthesis pathway) (simvastatin) (Simva) in human GBM cell lines and in primary human GBM cells in both cell monolayers and in three-dimensional (3D) cell culture systems. Learning Objectives: 1- The attendee will learn the concept of Cholesterol biosynthesis pathway and its possible effect in glioblastoma new therapy strategies. 2- The participant will learn concept of autophagy pathway. 3- The participant will understand how autophagy is involved in regulation of apoptosis. 4- The participant will learn the principal of glioblastoma 3D culture model. Short Biography: Saeid Ghavami got his BSc. in Chemistry in 1989 (Shiraz University, Shiraz, Iran), MSc. and PhD (1995, 2004, TMU University, Tehran, Iran) in Clinical Biochemistry. His Postdoctoral training was focused on the application of apoptosis/autophagy/unfolded protein response (UPR) in regulation of cell fate. His research program is focused on regulation of cellular phenotype via targeting autophagy and unfolded protein response in the Department of Human Anatomy and Cell Science, University of Manitoba, He has been the recipient of a number of prestigious awards including CIHR/GSK/CLA postdoctoral award (No #1 in Canada, 2007), Parker B Francis Career Development Award (top 10 in North America, 2009), ATS Science and Innovation Center Rising Star of Research Award (2017), CIHR/CCS/OICR Early Career Research Award (2017). He has published more than 150 peer reviewed article (google scholar: >12,800 citation, h-index 40) (scopous > 7800 citations, h-index 33). Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

1 0

MNN Seminar Series - Dr. Saeid Ghavami Fri Jan 25th @9am
by Manitoba Neuroscience Network 15 Jan '19

15 Jan '19

cid:image001.jpg@01D158FE.B69B8D00 M N N S E M I N A R & V I S I T I N G S P E A K E R S E R I E S D A T E Friday, January 25th, 2019 9am L O C A T I O N: Px236/238 PsycHealth Bldg. Bannatyne Campus S P E A K E R Dr. Saeid Ghavami Assistant Professor Human Anatomy & Cell Science Rady Faculty of Health Sciences T O P I C Glioblastoma and Cholesterol Metabolism Pathway Abstract: Temozolomide (TMZ) is chemotherapeutic agent for treatment of Grade IV Astrocytoma, otherwise known as Glioblastoma multiforme (GBM). TMZ treatment causes DNA damage and results in tumor cell apoptosis. TMZ also induces autophagy and causes tumor cell resistance and thus fails to improve the survival rate among patients. Statins are competitive inhibitors of the rate determining enzyme of the mevalonate (MEV) cascade and best known for their cholesterol (CH) lowering effect. Recently, it was reported that long-term consumption of statins, prior to and in parallel with other cancer therapeutic approaches, increased the survival rate of patients with various forms of cancers. In this talk, I present our latest investigation about the mechanisms of the potentiation of TMZ-induced apoptosis by MEV cascade inhibitor (cholesterol biosynthesis pathway) (simvastatin) (Simva) in human GBM cell lines and in primary human GBM cells in both cell monolayers and in three-dimensional (3D) cell culture systems. Learning Objectives: 1- The attendee will learn the concept of Cholesterol biosynthesis pathway and its possible effect in glioblastoma new therapy strategies. 2- The participant will learn concept of autophagy pathway. 3- The participant will understand how autophagy is involved in regulation of apoptosis. 4- The participant will learn the principal of glioblastoma 3D culture model. Short Biography: Saeid Ghavami got his BSc. in Chemistry in 1989 (Shiraz University, Shiraz, Iran), MSc. and PhD (1995, 2004, TMU University, Tehran, Iran) in Clinical Biochemistry. His Postdoctoral training was focused on the application of apoptosis/autophagy/unfolded protein response (UPR) in regulation of cell fate. His research program is focused on regulation of cellular phenotype via targeting autophagy and unfolded protein response in the Department of Human Anatomy and Cell Science, University of Manitoba, He has been the recipient of a number of prestigious awards including CIHR/GSK/CLA postdoctoral award (No #1 in Canada, 2007), Parker B Francis Career Development Award (top 10 in North America, 2009), ATS Science and Innovation Center Rising Star of Research Award (2017), CIHR/CCS/OICR Early Career Research Award (2017). He has published more than 150 peer reviewed article (google scholar: >12,800 citation, h-index 40) (scopous > 7800 citations, h-index 33). Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 . ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

1 0